AngTayKor, great sharing. As I posted earlier GB is a BLUE CHIP and still growing
Price now is VERY LOW. Potential is Very High soon. When TauRx gets licensing, price spike Time frame fast-tràck maybe < 1yr. GB price RM6 is done deal. Look at extremely conservative min RM7
For me, Taurx is still unknown Yeah, there's some positive light, but there's still many unknowns I would keep it as a bonus for now Bear in mind, the costs associated could be huge as well, say the variable cost margin is $20, final income to Taurx could be only $5 after deducting associate fees, multiple party interests and etc etc 20% of that is only $1 I'm not going to put a price on Taurx for now, until someone can show the true accounting. The potential TP can remain just a potential.
taurx is no tauhu, imo! it's just that little info is available right now and therefore the risks. don't know if it's monotherapy or must be used in combo with other drugs, 1st line or 3rd line options, side effect severity, other competition drugs already out there, timeline for approval, pricing, etc.
You worry too much. like this type of mentality can only become salary earner. of course there is bad time and good time. instead during bad time, it is the best time to collect cheap cheap good potential ticket..
Of course LKT has the foresight. Just look at how he put Genting HK into liquidation instead of agreeing to guarantee the huge German loans to the German shipyard. He played his cards right. Germany is well on its way to deindustrialisation.
Q2 is expected to be much better than Q1 for obvious reasons. Headwinds eg russ-ukr fighting, china remained closed, fear of global recessions outweighed the taurx good news
Ang, let’s just wait and see. I’m a Malaysian and of course I’d like a Malaysian company be involved in a successful treatment for AD (even if the Malaysian company is most famous for a “leisure drug” that have caused suicides)
Glaxo backs another company. There are 3 others currently in Ph2 trials. I think 2 of them are listed in Nasdaq
Posted by anthonytkh > 26 minutes ago | Report Abuse
Ang, let’s just wait and see. I’m a Malaysian and of course I’d like a Malaysian company be involved in a successful treatment for AD (even if the Malaysian company is most famous for a “leisure drug” that have caused suicides)
Glaxo backs another company. There are 3 others currently in Ph2 trials. I think 2 of them are listed in Nasdaq -----------------------------------------------------------------
All will fail their phase 3 trials. Spreading of misfolded Tau is the root and cause of AD. Even if competitors have some early stage of Tau research program, very difficult to be successful. The correct method is T.A.I = Tau Aggregate Inhibitor. There are good Tau which is essential for the functioning of brain. Some programs targeting the wrong tau, some using wrong method of application. Numerous Tau programs that has already failed. Not so simple. Lucidity's success is a cumulation of 35 years discovery, knowledge and extensive research.
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
anthonytkh
1,802 posts
Posted by anthonytkh > 2022-06-15 12:07 | Report Abuse
Ang, when I mentioned “too many hurdles”, I wasn’t talking about the drug’s successful trials
The FDA is corrupted. Red tapes aplenty. Big Pharma have huge influence.